LifeArc
LifeArc spends Keytruda cash on R&D ignored by pharma
Richard Staines
cancer, LifeArc, Merck & Co, MRC, neurology, R&D, UK biotech
0 Comment
Formerly known as MRC Technology, charity to spend Keytruda royalties on R&D considered too risky by big pharma
X
LifeArc spends Keytruda cash on R&D ignored by pharma
https://pharmaphorum.com/news/lifearc-spends-keytruda-cash-rd-ignored-pharma/